Key takeaways
- Dutasteride improved hair counts more than finasteride in a 24-week trial, but that does not establish the best long-term choice for everyone. Randomised trial.
- Both medicines reduce the formation of dihydrotestosterone, or DHT, through related but different enzyme effects. Trial background.
- Sexual side effects and mood changes deserve attention, not dismissal as anxiety about treatment. EMA safety review.
- The EMA confirmed suicidal thoughts as a side effect of finasteride tablets in 2025; the frequency is unknown. Regulatory findings.
Six months of scalp photographs can be more useful than checking the mirror every morning. When hair loss continues, it is tempting to search for a stronger blocker. The next step should be to establish whether treatment has failed, whether it has had enough time, and whether the diagnosis is right.
This comparison concerns male pattern hair loss. Sudden shedding, isolated bald patches or a painful scalp need a different assessment.
Is dutasteride more effective than finasteride?
One substantial head-to-head trial favoured dutasteride, but its follow-up lasted only 24 weeks.
The study included 917 men with androgenetic alopecia. The tested dutasteride regimen improved hair count and width more than the finasteride comparator. Side effects reported during the trial were broadly similar between groups. This is useful evidence, but a relatively short study cannot settle uncommon risks or years of treatment. Published trial.
| Question | Finasteride | Dutasteride |
|---|---|---|
| Main enzyme action | Mainly type 2 5-alpha reductase | Types 1 and 2 |
| Evidence in the comparison trial | Improved hair growth | Greater improvement at the tested regimen |
| Does this determine an individual’s choice? | No | No |
“Stronger” describes a drug effect, not a complete benefit-risk assessment. A treatment that produces more hair in a study may still be the wrong choice for someone experiencing side effects.
Which side effects should change the conversation?
New sexual symptoms, depression or thoughts of self-harm need prompt attention.
The EMA’s 2025 review confirmed suicidal thoughts as a side effect of finasteride tablets. It did not establish a direct link for dutasteride, but recommended precautionary information because of the similar mechanism. Sexual problems may also contribute to mood changes. EMA review.
For finasteride used for hair loss, the EMA advises stopping treatment and contacting a doctor if mood changes occur. Thoughts of self-harm require immediate help through emergency care. Do not wait for a routine hair-loss appointment.
Record when a symptom began and which medicines changed. That gives the clinician something concrete to assess. Neither an online success story nor a dismissive explanation about “nocebo” can establish what is happening to you.
What should you ask before switching?
Ask what a switch is expected to improve and how its benefits and harms will be followed.
Bring dated photographs taken in similar lighting, your treatment history and a list of adverse effects. Ask whether the prescription is for an approved indication or an off-label use in the country concerned. Overseas approval can be informative, but it does not answer that local prescribing question.
Also tell the clinician about fertility concerns, prostate investigations and other medicines. Do not use a prostate-treatment pack as a substitute for a hair-loss prescription or improvise a tablet-splitting schedule.
If you are comparing a DHT blocker with minoxidil, remember that these are different approaches. Our oral minoxidil article covers the evidence and cardiovascular considerations. Questions about testosterone and fertility are addressed separately in the enclomiphene and Clomid comparison.
Do and don’t
Do:
- Agree on a review date and use consistent photographs to judge progress.
- Raise sexual or mood symptoms even if you are unsure they are related.
Don’t:
- Treat greater DHT suppression as proof of greater personal benefit.
- Switch, combine or alter prescription medicines without a treatment plan.
